Allogeneic stem cell transplantation reduces the relapse incidence in patients with AML and normal karyotype independently of the FLT3-ITD status

被引：0
|
作者：
Schueller, F.
Maschmeyer, G.
Fischer, T.
Herold, M.
Sayer, H. G.
Wolf, H. -H.
Kreibich, U.
Haehling, D.
Doelken, G.
Junghanss, C.
Grobe, N.
Krahl, R.
Lange, T.
Al Ali, H. -K.
Basara, N.
Poenisch, W.
Niederwieser, D.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [21] Normal karyotype AML has a similar outcome post haematopoietic stem cell transplantation irrespective of FLT 3 ITD mutation status at diagnosis
    Fay, M.
    Elder, P.
    Browne, P.
    Conneally, E.
    Hayden, P.
    Neill, G. O.
    Nehhozina, T.
    Vandenberghe, E.
    Flynn, C.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S111 - S112
  • [22] Improved survival in AML patients with a high FLT3-ITD mutation rate after allogeneic transplantation
    Ehninger, G.
    Bornhaeuser, M.
    Kramer, M.
    Roellig, C.
    Wandt, H.
    Haenel, M.
    Einsele, H.
    Aulitzky, W.
    Schmidt, N.
    Berdel, W.
    Stelljes, M.
    Baldus, C.
    Mackensen, A.
    Platzbecker, U.
    Schaich, M.
    Thiede, C.
    Ho, A.
    Schetelig, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S3 - S3
  • [23] FLT3-ITD and Age Are the Major Prognostic Factors In Relapsed AML with Normal Karyotype.
    Krauter, Jurgen
    Wagner, Katharina
    Damm, Frederik
    Thol, Felicitas
    Fiedler, Walter
    Ottmann, Oliver G.
    Heit, Wolfgang F. W.
    Luebbert, Michael
    Raghavachar, Aruna
    Goehring, Gudrun
    Heuser, Michael
    Schlegelberger, Brigitte
    Heil, Gerhard
    Ganser, Arnold
    BLOOD, 2010, 116 (21) : 719 - 720
  • [24] FLT3-ITD but not FLT3-TKD mutations have major prognostic impact in normal karyotype AML
    Schneider, Stephanie
    Schneider, Friederike
    Dufour, Annika
    Mellert, Gudrun
    Zellmeier, Evelyn
    Braess, Jan
    Bohlander, Stefan K.
    Feuring-Buske, Michaela
    Buske, Christian
    Fritsch, Susanne
    Heinecke, Achim
    Sauerland, Maria C.
    Hoster, Eva
    Unterhalt, Michael
    Berdel, Wolfgang E.
    Wormann, Bernhard J.
    Buechner, Thomas
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    BLOOD, 2007, 110 (11) : 1021A - 1021A
  • [25] THE DNMT3A R882 MUTATION WITH FLT3-ITD POSITIVITY IS AN EXTREMELY POOR PROGNOSTIC FACTOR IN PATIENTS WITH NORMAL KARYOTYPE AML AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Ahn, J. S.
    Kim, H. J.
    Kim, Y. K.
    Jung, S. H.
    Yang, D. H.
    Lee, J. J.
    Kim, N. Y.
    Choi, S. H.
    Jung, C. W.
    Jang, J. H.
    Kim, H. J.
    Moon, J. H.
    Sohn, S. K.
    Won, J. H.
    Kim, S. H.
    Kim, D. D. H.
    HAEMATOLOGICA, 2015, 100 : 385 - 386
  • [26] Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML
    Meshinchi, Sohell
    Arceci, Robert J.
    Sanders, Jean E.
    Smith, Franklin O.
    Woods, William B.
    Radich, Jerald R.
    Alonzo, Todd A.
    BLOOD, 2006, 108 (01) : 400 - 400
  • [27] Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: A GOELAMS study
    Guieze, Romain
    Cornillet-Lefebvre, Pascale
    Lioure, Bruno
    Blanchet, Odile
    Pigneux, Arnaud
    Recher, Christian
    Bonmati, Caroline
    Fegueux, Nathalie
    Bulabois, Claude-Eric
    Bouscary, Didier
    Vey, Norbert
    Delain, Martine
    Turlure, Pascal
    Himberlin, Chantal
    Harousseau, Jean-Luc
    Dreyfus, Francois
    Bene, Marie C.
    Ifrah, Norbert
    Chevallier, Patrice
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (12) : 1052 - 1056
  • [28] Pretransplant FLT3-ITD levels predict outcome after allogeneic hematopoietic cell transplantation for AML patients in the first remission
    Li Wan
    Mingzhu Xu
    Jia Chen
    Zuyi Yang
    Mimi Xu
    Hongjie Shen
    Xiaojin Wu
    Shengli Xue
    Xiao Ma
    Yue Han
    Xiaowen Tang
    Huiying Qiu
    Depei Wu
    Yuejun Liu
    Bone Marrow Transplantation, 2020, 55 : 821 - 823
  • [29] Pretransplant FLT3-ITD levels predict outcome after allogeneic hematopoietic cell transplantation for AML patients in the first remission
    Wan, Li
    Xu, Mingzhu
    Chen, Jia
    Yang, Zuyi
    Xu, Mimi
    Shen, Hongjie
    Wu, Xiaojin
    Xue, Shengli
    Ma, Xiao
    Han, Yue
    Tang, Xiaowen
    Qiu, Huiying
    Wu, Depei
    Liu, Yuejun
    BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 821 - 823
  • [30] Sorafenib maintenance post-allogeneic HCT in reducing relapse of patients with FLT3-ITD AML: a systematic review
    Triaswhoro, G. L.
    Sito, W. W.
    Arivia, C.
    Sidharta, F.
    Atmadji, W.
    Angelius, C.
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1367 - S1367
12345